Activity ratios measure how efficiently a company performs day-to-day tasks, such us the collection of receivables and management of inventory.
Long-term Activity Ratios (Summary)
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
The analysis of long-term activity ratios reveals a significant divergence between fixed asset utilization and overall asset and equity efficiency. While the efficiency of fixed assets in generating revenue has steadily declined over the five-year period, the broader asset and equity turnover ratios demonstrate a pattern of resilience and recovery following a dip in 2020.
- Net Fixed Asset Turnover
- A consistent downward trend is observed in the net fixed asset turnover ratio, which decreased from 5.63 in 2018 to 2.76 by the end of 2022. This persistent decline suggests a diminishing return on investment in fixed assets or a significant expansion of the fixed asset base that has outpaced revenue growth.
- Net Fixed Asset Turnover Including Operating Leases
- The ratio incorporating right-of-use assets follows a similar downward trajectory, falling from 5.63 in 2018 to 2.56 in 2022. The widening gap between this metric and the standard net fixed asset turnover starting in 2019 indicates an increase in leased assets, which has further contributed to the reduction in overall fixed asset efficiency.
- Total Asset Turnover
- Total asset turnover remained relatively stable over the period, ending 2022 at 0.54, identical to the 2018 level. After a peak of 0.62 in 2019 and a trough of 0.45 in 2020, the ratio showed a gradual recovery, indicating that the company has maintained a consistent ability to generate sales relative to its total asset base despite the volatility in fixed asset efficiency.
- Equity Turnover
- Equity turnover exhibited a fluctuating pattern, peaking at 1.67 in 2019 before dropping sharply to 1.05 in 2020. A recovery trend followed, with the ratio rising to 1.36 by 2022. This suggests an initial increase in equity that outpaced revenue growth in 2020, followed by a period of improved efficiency in utilizing shareholder equity to drive sales.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Net Fixed Asset Turnover
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | ||||||
| Revenue | 2,909,800) | 2,448,500) | 1,926,700) | 1,476,000) | 1,031,600) | |
| Property and equipment, net | 1,055,600) | 801,800) | 515,300) | 321,300) | 183,100) | |
| Long-term Activity Ratio | ||||||
| Net fixed asset turnover1 | 2.76 | 3.05 | 3.74 | 4.59 | 5.63 | |
| Benchmarks | ||||||
| Net Fixed Asset Turnover, Competitors2 | ||||||
| Abbott Laboratories | 4.76 | 4.81 | — | — | — | |
| Elevance Health Inc. | 36.07 | 34.94 | — | — | — | |
| Intuitive Surgical Inc. | 2.62 | 3.04 | — | — | — | |
| Medtronic PLC | 5.85 | 5.77 | — | — | — | |
| UnitedHealth Group Inc. | 31.81 | 31.81 | — | — | — | |
| Net Fixed Asset Turnover, Sector | ||||||
| Health Care Equipment & Services | 17.82 | 17.31 | — | — | — | |
| Net Fixed Asset Turnover, Industry | ||||||
| Health Care | 7.88 | 7.74 | — | — | — | |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Net fixed asset turnover = Revenue ÷ Property and equipment, net
= 2,909,800 ÷ 1,055,600 = 2.76
2 Click competitor name to see calculations.
A comprehensive review of the long-term investment activity reveals a period of aggressive capital expansion relative to revenue growth between 2018 and 2022.
- Revenue Growth Trends
- Revenue demonstrated a consistent and significant upward trajectory, increasing from 1,031,600 thousand US dollars in 2018 to 2,909,800 thousand US dollars by the end of 2022. This reflects a strong and steady expansion of the company's top-line performance over the five-year period.
- Fixed Asset Investment
- Net property and equipment grew at a rate that substantially outpaced revenue growth. Net fixed assets rose from 183,100 thousand US dollars in 2018 to 1,055,600 thousand US dollars in 2022. This indicates a period of intensive capital expenditure focused on increasing production capacity or expanding infrastructure.
- Net Fixed Asset Turnover Performance
- The net fixed asset turnover ratio experienced a continuous and marked decline, falling from 5.63 in 2018 to 2.76 in 2022. This downward trend indicates that the company is generating fewer dollars of revenue for every dollar invested in net fixed assets. Such a pattern typically suggests that the recent large-scale investments in property and equipment have not yet reached full operational maturity or optimal revenue-generating efficiency.
In summary, the observed data indicates a strategic phase of heavy capital investment. While revenue is growing, the rapid accumulation of net fixed assets has led to a reduction in asset utilization efficiency, as the investment in capacity is currently exceeding the rate of revenue realization.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset)
DexCom Inc., net fixed asset turnover (including operating lease, right-of-use asset) calculation, comparison to benchmarks
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | ||||||
| Revenue | 2,909,800) | 2,448,500) | 1,926,700) | 1,476,000) | 1,031,600) | |
| Property and equipment, net | 1,055,600) | 801,800) | 515,300) | 321,300) | 183,100) | |
| Operating lease right-of-use assets | 80,000) | 88,100) | 93,300) | 71,500) | —) | |
| Property and equipment, net (including operating lease, right-of-use asset) | 1,135,600) | 889,900) | 608,600) | 392,800) | 183,100) | |
| Long-term Activity Ratio | ||||||
| Net fixed asset turnover (including operating lease, right-of-use asset)1 | 2.56 | 2.75 | 3.17 | 3.76 | 5.63 | |
| Benchmarks | ||||||
| Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset), Competitors2 | ||||||
| Abbott Laboratories | 4.25 | 4.26 | — | — | — | |
| Elevance Health Inc. | 31.64 | 30.12 | — | — | — | |
| Intuitive Surgical Inc. | 2.53 | 2.93 | — | — | — | |
| Medtronic PLC | 5.06 | 4.84 | — | — | — | |
| UnitedHealth Group Inc. | 21.54 | 21.54 | — | — | — | |
| Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset), Sector | ||||||
| Health Care Equipment & Services | 14.39 | 13.89 | — | — | — | |
| Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset), Industry | ||||||
| Health Care | 6.90 | 6.75 | — | — | — | |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Net fixed asset turnover (including operating lease, right-of-use asset) = Revenue ÷ Property and equipment, net (including operating lease, right-of-use asset)
= 2,909,800 ÷ 1,135,600 = 2.56
2 Click competitor name to see calculations.
Between 2018 and 2022, a consistent increase in both total revenue and net fixed assets, including operating lease right-of-use assets, was observed. Revenue grew from 1,031,600 thousand US$ to 2,909,800 thousand US$, demonstrating a sustained upward trajectory. Simultaneously, net fixed assets expanded significantly from 183,100 thousand US$ to 1,135,600 thousand US$, indicating an aggressive expansion of the long-term infrastructure and operational capacity.
- Net Fixed Asset Turnover Trend
- A steady downward trend in the net fixed asset turnover ratio is observed, declining from 5.63 in 2018 to 2.56 in 2022. This decrease indicates that the growth in the fixed asset base has outpaced the growth in revenue generated from those assets during this period.
- Asset Utilization Efficiency
- The contraction of the ratio suggests a period of intensive capital expenditure. While revenue grew substantially over the five-year period, the fixed asset base increased at a faster rate, leading to a reduction in the immediate efficiency of asset utilization per unit of investment.
- Strategic Capacity Expansion
- The observed pattern is characteristic of a scaling phase where significant investments in property, equipment, and leasehold assets are deployed to support future growth. The diminishing turnover ratio reflects the typical temporal lag between the acquisition of large-scale capital assets and the full realization of the corresponding revenue streams.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Total Asset Turnover
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | ||||||
| Revenue | 2,909,800) | 2,448,500) | 1,926,700) | 1,476,000) | 1,031,600) | |
| Total assets | 5,391,700) | 4,863,600) | 4,290,500) | 2,395,000) | 1,916,000) | |
| Long-term Activity Ratio | ||||||
| Total asset turnover1 | 0.54 | 0.50 | 0.45 | 0.62 | 0.54 | |
| Benchmarks | ||||||
| Total Asset Turnover, Competitors2 | ||||||
| Abbott Laboratories | 0.59 | 0.57 | — | — | — | |
| Elevance Health Inc. | 1.51 | 1.41 | — | — | — | |
| Intuitive Surgical Inc. | 0.48 | 0.42 | — | — | — | |
| Medtronic PLC | 0.35 | 0.32 | — | — | — | |
| UnitedHealth Group Inc. | 1.31 | 1.34 | — | — | — | |
| Total Asset Turnover, Sector | ||||||
| Health Care Equipment & Services | 1.06 | 1.02 | — | — | — | |
| Total Asset Turnover, Industry | ||||||
| Health Care | 0.66 | 0.62 | — | — | — | |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Total asset turnover = Revenue ÷ Total assets
= 2,909,800 ÷ 5,391,700 = 0.54
2 Click competitor name to see calculations.
Revenue demonstrates consistent year-over-year growth from 2018 to 2022, increasing from approximately $1.03 billion to $2.91 billion. Total assets followed a similar growth trajectory but exhibited a more pronounced expansion in 2020, nearly doubling from the previous year's valuation.
- Total Asset Turnover Trend
- The asset turnover ratio exhibited volatility over the five-year period, starting at 0.54 in 2018, peaking at 0.62 in 2019, and subsequently declining to a low of 0.45 in 2020. A recovery phase followed, with the ratio ascending to 0.50 in 2021 and returning to 0.54 by the end of 2022.
- Asset Utilization Efficiency
- A significant divergence between asset growth and revenue generation occurred in 2020. While revenue grew by approximately 30% during that year, total assets increased by roughly 79%. This imbalance resulted in the observed dip in the turnover ratio, indicating that the rapid expansion of the asset base initially outpaced the company's ability to generate proportional sales.
- Investment Recovery and Optimization
- The upward trend in the ratio from 2021 to 2022 suggests an improving efficiency in leveraging the expanded asset base. The return to a 0.54 ratio by 2022 indicates that the investments made during the 2020 expansion are being more effectively converted into top-line revenue growth.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Equity Turnover
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | ||||||
| Revenue | 2,909,800) | 2,448,500) | 1,926,700) | 1,476,000) | 1,031,600) | |
| Stockholders’ equity | 2,131,800) | 2,251,500) | 1,826,500) | 882,600) | 663,300) | |
| Long-term Activity Ratio | ||||||
| Equity turnover1 | 1.36 | 1.09 | 1.05 | 1.67 | 1.56 | |
| Benchmarks | ||||||
| Equity Turnover, Competitors2 | ||||||
| Abbott Laboratories | 1.19 | 1.20 | — | — | — | |
| Elevance Health Inc. | 4.29 | 3.80 | — | — | — | |
| Intuitive Surgical Inc. | 0.56 | 0.48 | — | — | — | |
| Medtronic PLC | 0.60 | 0.59 | — | — | — | |
| UnitedHealth Group Inc. | 4.14 | 3.98 | — | — | — | |
| Equity Turnover, Sector | ||||||
| Health Care Equipment & Services | 2.61 | 2.42 | — | — | — | |
| Equity Turnover, Industry | ||||||
| Health Care | 1.69 | 1.67 | — | — | — | |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Equity turnover = Revenue ÷ Stockholders’ equity
= 2,909,800 ÷ 2,131,800 = 1.36
2 Click competitor name to see calculations.
Revenue exhibited consistent and substantial growth over the five-year period, increasing from 1,031,600 thousand US dollars in 2018 to 2,909,800 thousand US dollars in 2022. This steady upward trajectory indicates a strong expansion of the company's top-line performance.
- Stockholders' Equity Trends
- A significant increase in stockholders' equity was observed between 2018 and 2021, rising from 663,300 thousand US dollars to a peak of 2,251,500 thousand US dollars. The most pronounced growth occurred between 2019 and 2020, where equity more than doubled. A slight contraction in equity was noted in 2022, decreasing to 2,131,800 thousand US dollars.
- Equity Turnover Analysis
- The equity turnover ratio demonstrated a fluctuating pattern. After an initial increase from 1.56 in 2018 to 1.67 in 2019, the ratio experienced a sharp decline to 1.05 in 2020. This decrease was primarily driven by the rapid expansion of the equity base outpacing the growth in revenue during that period.
- Efficiency Recovery
- Beginning in 2021, a recovery trend in asset utilization efficiency is evident. The equity turnover ratio rose to 1.09 in 2021 and further climbed to 1.36 in 2022. This improvement indicates that the company began generating more revenue per unit of equity, aided by continued revenue growth and a modest reduction in total stockholders' equity in the final year.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?